For optometry and ophthalmology platforms that keep the name on the door: the Care Revenue Engine installed under every brand, a phone that books before the office opens, recall that recovers revenue already paid for, and an owner pipeline that replaces the broker.
The consolidation of American eye care is a scoreboard, not a thesis. The share of optometrists in private practice fell from 51 to 41 percent between 2017 and 2024 while the share in private-equity-owned offices tripled to 10.9 percent (Review of Optometry citing AOA data, 2025); close to 50 PE-backed platforms (Vision Monday, 2024) have closed 313 deals worth $17.0 billion since 2019 (Vision Monday, 2025). Consumers still prefer a private-practice optometrist to a corporate one by roughly four to one (Review of Optometric Business citing VisionWatch and AOA data, 2025), which is the asset a name-keeping platform pays for and then has no system to scale.
The lead is cheap and the door is leaky. Eye care posts a $30.88 cost per lead on a $4.95 click at an 18.29 percent conversion rate, second-lowest of sixteen specialties (LocaliQ, 2026). But 33 percent of business-hour calls go unanswered and 47 percent of bookings happen after hours in the closest published multi-location analog (TrueLark/Weave via Group Dentistry Now, 2024), optometry's no-show rate runs about 25 percent (Solutionreach, 2024), and fewer than half of patients respond to recall (20/20 Magazine, 2015). Growth lives in the medical exam, which rises from 60 million to more than 76 million visits by 2030 while routine exams stay flat (Review of Optometric Business, 2025). And the owner who sells in 2029 takes two to five years to decide (Cleinman Performance Partners, 2025) while brokers charge 6 to 12 percent of the price (OMNI Practice Group, 2024).
Eye care has the opposite cost structure and the same leak: the cheapest lead in healthcare, lost inside the platform's own building.
We are a healthcare growth firm built in the hardest patient-acquisition market in medicine — addiction and behavioral-health treatment, through our behavioral health practice, Recovery Marketing Consultants — and we install the same engine across healthcare because the mechanics transfer. In treatment, a qualified call costs four figures and the business lives or dies on whether the phone is answered in the first minute and the lead is followed for ninety days. Eye care has the opposite cost structure and the same leak: the cheapest lead in healthcare, lost inside the platform's own building.
What transfers is the system: multi-location demand under separate names, a trained front-desk conversion layer, long-cycle nurture for a decision that takes years, and the accountability that makes your scheduler's answer rate and your development lead's conversation count visible every morning.
The Care Revenue Engine runs two engines on six stages: a local demand engine that wins patients for every brand, and a practice pipeline engine that wins the owners who are not ready yet.
Under every brand: local pages by condition, service and neighborhood; every Google Business Profile at the consumer's threshold of 4.5 stars, twenty-plus reviews and three-month recency (BrightLocal, 2026); brand-defense search plus symptom- and condition-stage keywords that reach the medical patient the plan never sends; seasonal paid social for myopia, dry eye, back-to-school and benefits reset. The owner track runs sequenced outreach to owner-optometrists from the NPPES registry and license rolls.
Demand GenerationA first response in under sixty seconds at every brand, any hour: missed-call text-back, conversational AI that books the exam after hours, text confirmations and reminders, and recall as a multi-channel sequence on a fourteen-month clock for contact-lens patients and twelve for spectacle patients.
Patient EngagementYour schedulers, trained to answer in each practice's own name and verify benefits before the visit; your patient coordinators, who own recall and the medical-visit conversion; and your practice development team — market analyst, development lead, chief development officer — equipped for the owner funnel. Everyone is trained in Care Conversations under the rules at How We Sell.
Conversion and TrainingReferral programs with primary care and endocrinology for the diabetic exam, ophthalmology co-management surgeon by surgeon, pediatrician and school screening programs, and employer benefits partnerships; and the proprietary owner-relationship database with a Practice Readiness Score and a two-year nurture. The database stays with you.
Referral and Partner GrowthRecall response measured within 60 days of the due date, reactivation of patients lapsed beyond 24 months with new information rather than "we miss you," annual-supply automation for contact-lens wearers, and a managed review program per location.
RetentionOne CRM as the system of record for every patient inquiry and every owner relationship, call tracking by brand, EHR integration so exam, optical and recall outcomes are attributed to the campaign and scheduler that produced them, dashboards by brand and location, and a due-diligence package at exit.
Data and AttributionThe Local-Brand Paradox, patient and practice acquisition economics, the platforms and their sponsors, the rules of the road, and the two-sided engine that fixes both funnels.
Read the playbookTargets are Care Marketers engineering targets, not industry averages. Taken from the playbook's benchmarks table.
| Metric | Industry baseline (sourced) | Care Revenue Engine target |
|---|---|---|
| Business-hour call answer rate | ~67%; 33% of calls missed (TrueLark/Weave, 2024) | 95%+ |
| Speed to first response, web and text | Next business day is common; 47% of bookings after hours (TrueLark/Weave, 2024) | Under 60 seconds, 24/7; follow-up from your trained team within 5 minutes |
| No-show rate | ~25% in optometry (Solutionreach, 2024) | Under 10% |
| Recall response | Under 50% (20/20 Magazine, 2015) | 70%+ within 60 days of due date |
| Location review standard | 4.5 stars, 20+ reviews, 3-month recency (BrightLocal, 2026) | Every location ≥ 4.5 stars, ≥ 50 reviews, ≥ 8 new per month |
| Cost per booked exam | ~$28 median; $42–75 in major metros (Redefine Web agency data, 2025–26) | At or below the metro median while volume scales |
| Marketing attribution | Typically none by location, campaign or keyword | Closed-loop from click or call to exam, optical and recall, by brand |
| Qualified owner conversations per month | Ad hoc, broker-dependent | 15+ (planning assumption for an 18-practice year) |
| Broker-sourced share of closed deals | The majority for most platforms | Under 30% within 24 months |
| Fee cost per acquired practice | 6–12% of price on brokered deals (OMNI Practice Group, 2024) | 0–3% on direct-sourced deals |
Because the mechanics are the same and we built them where an unanswered phone costs the most. Multi-location demand under separate names, a trained front-desk conversion layer, a long-cycle relationship funnel and a scoreboard by location are what fill treatment programs, and they are what grow a platform same-store. The playbook above is our evidence that we studied your business first.
Yes. Every stage runs under each practice's own brand, doctors and staff. The four-to-one consumer preference for a private-practice optometrist is the asset; we scale the systems behind it, not the sign.
We enumerate every independent practice in your markets from the NPPES registry and commercial data, score each for readiness from tenure, staffing signals and engagement with your content, and run a two-year nurture built around the owner's real questions, starting with "what is my practice worth."
Not for patient campaigns. Google bars health advertisers from remarketing and customer-list audiences, and Meta removed lower-funnel optimization and lookalikes from health data sources in 2025 (Google Ads policy; Wheelhouse DMG, 2025). Google's May 2025 update exempts campaigns aimed at licensed healthcare professionals, which is how the owner track runs. See HIPAA-Compliant Marketing.
Plans pay $35 to $90 for an exam Medicare reimburses at $114 (AOA, 2020), so we market deliberately for the patient the plan never sends: medical, contact-lens, pediatric and diabetic, through condition-stage content and physician referral programs, with autonomous diabetic-retinopathy screening now billable under CPT 92229 (Optos, 2026).
Book a strategy consultation. We will audit the door, the phone and the pipeline across your brands, model the same-store and acquisition uplift available in your markets, and outline the 90-day path to installing the engine.